Skip to main content
logo
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,620.90
-15.30 (-0.94%)
Oct 3, 2025, 10:30 AM IST

Revenue by Product

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2013 - 2020
India Formulations
169.23B
Log In
Log In
Log In
Log In
Upgrade
India Formulations Growth
13.09%
Log In
Log In
Log In
Log In
Upgrade
US Formulations
162.40B
Log In
Log In
Log In
Log In
Upgrade
US Formulations Growth
6.69%
Log In
Log In
Log In
Log In
Upgrade
Active Pharmaceutical Ingredients (API)
21.29B
Log In
Log In
Log In
Log In
Upgrade
Active Pharmaceutical Ingredients (API) Growth
16.08%
Log In
Log In
Log In
Log In
Upgrade
Others Segment
1.70B
Log In
Log In
Log In
Log In
Upgrade
Others Segment Growth
-28.65%
Log In
Log In
Log In
Log In
Upgrade
Emerging Market
94.16B
Log In
Log In
Log In
Log In
Upgrade
Emerging Market Growth
8.55%
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Formulations
71.63B
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Formulations Growth
11.43%
Log In
Log In
Log In
Log In
Upgrade
Other Operating
5.37B
Log In
Log In
Log In
Log In
Upgrade
Other Operating Growth
-33.29%
Log In
Log In
Log In
Log In
Upgrade

Other

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2013 - 2020
Sales per Medical Representative
11.20M
Log In
Log In
Log In
Log In
Upgrade
Sales per Medical Representative Growth
-
Log In
Log In
Log In
Log In
Upgrade
Number of Medical Representatives
15.11K
Log In
Log In
Log In
Log In
Upgrade
Number of Medical Representatives Growth
-
Log In
Log In
Log In
Log In
Upgrade